Boston Scientific Corporation has approved its 2026 Annual Bonus Plan, which will provide eligible employees, including named executive officers, with annual cash incentives based on performance metrics for the year beginning January 1, 2026. The bonus pool is determined by multiplying total target bonuses by a distribution percentage, which the Compensation Committee will set between 0% and 150% based on the company's global sales, adjusted earnings per share, operating income as a percent of sales, and corporate sustainability goals. Additionally, the company has adopted two new performance share programs for 2026: one based on relative total shareholder return compared to the S&P 500 Healthcare Index over three years, and another focused on organic net sales growth. These programs are similar to those implemented in the previous year.